Are New beta-Lactam/beta-Lactamase Inhibitors Viable Carbapenem Sparing Options for Treating Serious Infections Caused by Extended-Spectrum beta-Lactamase-Producing Microorganisms?

Title

Are New beta-Lactam/beta-Lactamase Inhibitors Viable Carbapenem Sparing Options for Treating Serious Infections Caused by Extended-Spectrum beta-Lactamase-Producing Microorganisms?

Creator

Kallstrom G

Publisher

Infectious Diseases in Clinical Practice

Date

2019
2019-05

Subject

Infectious Diseases; Immunology; escherichia-coli; susceptibility; cephalosporins

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Search for Full-text

Users with a NEOMED Library login can search for full-text journal articles at the following url: https://libraryguides.neomed.edu/home

Pages

121–122

Issue

3

Volume

27

ISSN

1056-9103

Citation

Kallstrom G, “Are New beta-Lactam/beta-Lactamase Inhibitors Viable Carbapenem Sparing Options for Treating Serious Infections Caused by Extended-Spectrum beta-Lactamase-Producing Microorganisms?,” NEOMED Bibliography Database, accessed January 19, 2021, https://neomed.omeka.net/items/show/6438.

Social Bookmarking